FIGURE 7.

Antibacterial activities of biogenic CuO nanoparticles at 50 μg mL⁻¹ the concentrationagainst (A) Xanthomonas Sp. (B) E. coli using (a) well diffusion method (b) disc diffusion method along with Rifampicin 5 μg mL⁻¹ and Neomycin 30 μg mL⁻¹.